MedPath

COVID-19 Remote Monitoring

Not Applicable
Withdrawn
Conditions
COVID-19
Cardiac Arrhythmias
Registration Number
NCT04350476
Lead Sponsor
Vivek Reddy
Brief Summary

The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting.

Detailed Description

The objective of the study is to assess the impact of remote cardiac and vital sign monitoring in patients with coronavirus disease (COVID-19) in the outpatient setting. This study will enroll COVID-19 positive patients previously evaluated at Mount Sinai Hospital/Mount Sinai Health System (MSHS) and affiliated hospitals deemed appropriate for home monitoring. Patients will be monitored remotely in the outpatient setting for 1-3 weeks following diagnosis and/or treatment for COVID-19 at MSH/MSHS.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patients diagnosed with coronavirus and determined to be eligible for home monitoring and self-care, and either

    1. Not admitted to the hospital, and permitted to recover at home
    2. Discharged from inpatient hospitalization, during the acute recovery period
  • 18 years old or older with the ability to understand the requirements of the study and sign the informed consent form (or able to provide over-the-phone verbal consent).

Exclusion Criteria

N/A

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of different arrhythmias7-14 Days

ac rhythm in patients with COVID-19 infection following treatment/discharge from MSH

Temperature7-14 Days

Temperature of patients with COVID-19 infection following treatment/discharge from MHS

Oxygen Saturation7-14 Days

Oxygen saturation level in patients with COVID-19 infection following treatment/discharge from MSH

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.